|1.||Li, Yan Chun: 24 articles (07/2015 - 04/2002)|
|2.||Feldman, David: 23 articles (08/2015 - 11/2002)|
|3.||Malloy, Peter J: 17 articles (01/2014 - 11/2002)|
|4.||Kong, Juan: 15 articles (09/2013 - 04/2002)|
|5.||Welsh, JoEllen: 14 articles (08/2015 - 12/2002)|
|6.||Wu-Wong, J Ruth: 14 articles (02/2015 - 01/2006)|
|7.||Reichrath, Jörg: 14 articles (01/2015 - 01/2002)|
|8.||Adorini, Luciano: 14 articles (06/2010 - 06/2002)|
|9.||Bikle, Daniel D: 13 articles (05/2015 - 10/2005)|
|10.||Muñoz, Alberto: 11 articles (01/2013 - 09/2004)|
|1.||Kidney Diseases (Kidney Disease)
08/01/2008 - "Vitamin D receptor activation is associated with improved survival in patients with chronic kidney disease, but the mechanism of this benefit is unclear. "
06/01/2015 - "Ability of vitamin D receptor activator to prevent pulmonary congestion in advanced chronic kidney disease."
02/01/2015 - "Association of vitamin D receptor (VDR) BsmI (rs1544410) gene polymorphism with the chronic kidney disease (CKD) susceptibility from the published reports are still conflicting. "
02/01/2015 - "Association of vitamin D receptor BsmI (rs1544410) gene polymorphism with the chronic kidney disease susceptibility."
02/01/2015 - "Relationship between vitamin D receptor (VDR) gene polymorphism and the risk of chronic kidney disease (CKD) from the published reports are still conflicting. "
01/01/2013 - "Vitamin D receptors (VDRs) are ubiquitous and their activation has shown protective effects against secondary hyperparathyroidism development and anti-hypertensive, anti-inflammatory, anti-fibrotic, immunomodulating, anti-proliferative, anti-diabetic and anti-proteinuric properties. "
03/01/2015 - "Vitamin D receptor activators (VDRAs), which are traditionally considered a cardinal treatment of secondary hyperparathyroidism, have attracted lots of attention for their potential pleiotropic effects through the activation of the vitamin D receptor expressed in multiple organs. "
01/01/2015 - "All these changes can also influence vitamin D receptor (VDR) activation and the development of secondary hyperparathyroidism (SHPT). "
01/01/2013 - "Activation of vitamin D receptors in the optimization of hyperparathyroidism secondary to dialysis."
11/01/2012 - "In a comparison of the 4 most frequently performed bariatric operations vitamin-D-receptor polymorphism (VDRP) had no influence on the development of postoperative secondary hyperparathyroidism (SHPT) and is not useful as a predictor. "
|3.||Hypercalcemia (Milk Alkali Syndrome)
06/01/2010 - "A nonsecosteroidal vitamin D receptor ligand with improved therapeutic window of bone efficacy over hypercalcemia."
10/01/2014 - "PS121912 has been developed as selective vitamin D receptor (VDR)-coregulator inhibitor starting from a high throughput screening campaign to identify new agents that modulate VDR without causing hypercalcemia. "
04/01/2011 - "As its clinical application is limited by hypercalcemia, synthetic vitamin D receptor (VDR) agonists that mediate immunomodulatory activities without adverse hypercalcemic effects are of great interest. "
10/28/2010 - "Vitamin D receptor (VDR) antagonists have therapeutic potential in treatment of allergic conditions and hypercalcemia driven by granulomatous diseases. "
02/01/2005 - "Association of vitamin D receptor gene polymorphisms with hypercalcemia in peritoneal dialysis patients."
04/01/2015 - "Critical roles of intestinal epithelial vitamin D receptor signaling in controlling gut mucosal inflammation."
01/01/2015 - "Vitamin D receptor activation (VDRA) plays an important role in mineral metabolism and inflammation, but also antiangiogenic and antifibrotic properties have been reported. "
12/01/2014 - "Drugs currently investigated for the treatment of prostatic inflammation include the hexanic lipidosterolic extract of Serenoa repens, nonsteroidal anti-inflammatory drugs, and vitamin D receptor agonists. "
04/01/2014 - "We also observed that MEF2C binding sites were significantly enriched primarily near inflammation associated genes identified from GWAS; indeed, a similar enrichment for inflammation genes has been reported previously using a similar approach for the vitamin D receptor, an established key regulator of bone turnover. "
01/01/2014 - "Vitamin D receptor expression controls proliferation of naïve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation."
|5.||Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
07/01/2010 - "To date, there have been no reports showing the efficacy of nonsecosteroidal vitamin D receptor (VDR) agonists in a benign prostatic hyperplasia (BPH) animal model. "
01/01/2015 - "The aim of the study was to investigate the association between single nucleotide polymorphism (SNP) of vitamin D receptor (VDR) gene and clinical progress of benign prostatic hyperplasia (BPH) in Chinese men. "
01/01/2015 - "Association between single nucleotide polymorphism of vitamin D receptor gene FokI polymorphism and clinical progress of benign prostatic hyperplasia."
10/01/2014 - "The association between vitamin D receptor (VDR) gene polymorphisms and risk of benign prostatic hyperplasia (BPH) has been investigated in numerous publications, but published results remain inconclusive. "
10/01/2014 - "Meta-analysis of vitamin D receptor gene polymorphisms and benign prostatic hyperplasia risk."
|4.||methyl 4-azidophenylacetimidate (APAI)
|8.||Parathyroid Hormone (Parathormone)
|1.||Renal Dialysis (Hemodialysis)
|3.||Hormone Replacement Therapy (Therapy, Hormone Replacement)
|4.||Transplantation (Transplant Recipients)